EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a simultaneous LC–MS/MS analytical method for plasma: 16 antipsychotics approved in Japan and 4 drug metabolites

Masamitsu Maekawa, Maki Yokota, Toshihiro Sato, Yu Sato, Masaki Kumondai, Yuji Sato, Masato Suzuka, Daisuke Kobayashi, Kotaro Sakamoto, Masaki Matsuura, Masafumi Kikuchi, Hiroshi Komatsu und 4 weitere

Analytical Sciences · 2024

DOI: 10.1007/s44211-024-00619-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Sciences, 2024. Verfasst von Masamitsu Maekawa und 15 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Sciences, Tohoku University, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan. masamitsu.maekawa.a2@tohoku.ac.jp. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Antipsychotic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Tohoku Branch of the Japan Society of Analytical Chemistry.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The increased risk of adverse drug reactions due to the concomitant use of antipsychotics is problematic in the treatment of schizophrenia. Therefore, the simultaneous analysis of their plasma concentrations is required. In this study, we developed a simultaneous liquid chromatography/tandem mass spectrometry (LC–MS/MS) method for analyzing plasma antipsychotics approved in Japan for therapeutic drug monitoring (TDM) applications. First, we counted the prescriptions for 16 antipsychotics and concomitant drugs used at the Tohoku University Hospital. LC–MS/MS was used for the simultaneous analysis of 16 antipsychotics and four drug metabolites. This analysis was conducted using a combination of selected reaction monitoring mode and reversed-phase chromatography. Following the examination of the MS/MS and LC conditions, an analytical method validation test was conducted. The developed method was used to analyze plasma antipsychotic levels in patients with schizophrenia. One-third of the patients received treatment with multiple antipsychotics. Under LC–MS/MS conditions, LC separation was performed using a combination of a C18 column and ammonium formate-based mobile phases with a gradient flow. The calibration curves were optimized by adjusting the ion abundance, and 11 compounds met the criteria for intra- and inter-day reproducibility tests. Some stability test results did not meet these criteria; therefore, further investigation is required. The developed method permitted the measurement of all the plasma parameters, including concentrations above the therapeutic range. Therefore, this method may be useful in the daily TDM practice of antipsychotics. Graphical abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryAntipsychotic AgentsJapanHumansChromatography, LiquidSchizophreniaDrug MonitoringBlood Chemical AnalysisLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

AntipsychoticsLC–MS/MSPlasma drug concentrationsSchizophreniaSimultaneous analysis

Substanzen

Antipsychotic Agents

Autor:innen und Institutionen

  • Faculty of Pharmaceutical Sciences, Tohoku University, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan. masamitsu.maekawa.a2@tohoku.ac.jp.
  • Department of Pharmaceutical Sciences, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan. masamitsu.maekawa.a2@tohoku.ac.jp.
  • Faculty of Pharmaceutical Sciences, Tohoku University, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
  • Department of Pharmaceutical Sciences, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
  • Department of Psychiatry, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
  • Department of Psychiatry, Shiga University of Medical Science, Otsu, 520-2192, Japan.

Förderung

  • The Tohoku Branch of the Japan Society of Analytical Chemistry

Zitieren

APA

Maekawa, M., Yokota, M., Sato, T., Sato, Y., Kumondai, M., Sato, Y., Suzuka, M., Kobayashi, D., Sakamoto, K., Matsuura, M., Kikuchi, M., Komatsu, H., Fujii, K., Ozeki, Y., Tomita, H., & Mano, N. (2024). Development of a simultaneous LC–MS/MS analytical method for plasma: 16 antipsychotics approved in Japan and 4 drug metabolites. Analytical Sciences. https://doi.org/10.1007/s44211-024-00619-2

Vancouver

Maekawa M, Yokota M, Sato T, Sato Y, Kumondai M, Sato Y, et al. Development of a simultaneous LC–MS/MS analytical method for plasma: 16 antipsychotics approved in Japan and 4 drug metabolites. Analytical Sciences. 2024. doi:10.1007/s44211-024-00619-2

BibTeX
@article{Maekawa2024,
  author = {Maekawa, Masamitsu and Yokota, Maki and Sato, Toshihiro and Sato, Yu and Kumondai, Masaki and Sato, Yuji and Suzuka, Masato and Kobayashi, Daisuke and Sakamoto, Kotaro and Matsuura, Masaki and Kikuchi, Masafumi and Komatsu, Hiroshi and Fujii, Kumiko and Ozeki, Yuji and Tomita, Hiroaki and Mano, Nariyasu},
  title = {Development of a simultaneous LC–MS/MS analytical method for plasma: 16 antipsychotics approved in Japan and 4 drug metabolites},
  journal = {Analytical Sciences},
  year = {2024},
  doi = {10.1007/s44211-024-00619-2}
}
Kostenlos starten →